| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Pearay L Ogra | |
| P2860 | cites work | Recovery of cytopathogenic agent from chimpanzees with coryza | Q74223084 |
| Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae | Q33938539 | ||
| Respiratory syncytial virus and parainfluenza virus | Q33952428 | ||
| Respiratory syncytial virus infections in immunocompromised adults | Q34004104 | ||
| Asthma. | Q34137112 | ||
| Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. | Q35856437 | ||
| Secretory component and sudden-infant-death syndrome | Q39342623 | ||
| Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation | Q39877332 | ||
| Respiratory Syncytial Virus Infections within Families | Q39969793 | ||
| Respiratory syncytial virus | Q40485832 | ||
| Characteristics of IL-6 and TNF-alpha production by respiratory syncytial virus-infected macrophages in the neonate | Q41231169 | ||
| Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases | Q41463119 | ||
| Characteristics of in vitro production of mucosal antibody to respiratory syncytial virus in tonsillar tissue lymphocytes | Q41953814 | ||
| Respiratory viruses and sudden infant death | Q43071603 | ||
| Neonatal respiratory syncytial virus infection | Q44267961 | ||
| Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia | Q44937806 | ||
| RESPIRATORY SYNCYTIAL VIRUS NEUTRALIZING ANTIBODIES IN PERSONS RESIDING IN CHICAGO, ILLINOIS. | Q45713855 | ||
| Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. | Q45719599 | ||
| Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. | Q45719601 | ||
| Respiratory syncytial virus and reactive airway disease. New developments prompt a new review | Q45738208 | ||
| Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus | Q45788576 | ||
| The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses | Q45791349 | ||
| Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay | Q45794505 | ||
| The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection | Q45805502 | ||
| P921 | main subject | virus | Q808 |
| P304 | page(s) | S119-26 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Paediatric Respiratory Reviews | Q15759971 |
| P1476 | title | Respiratory syncytial virus: the virus, the disease and the immune response | |
| P478 | volume | 5 Suppl A |
| Q89925090 | A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates |
| Q36112922 | Acute and long-term effects of infection by the respiratory syncytial virus in children with congenital cardiac malformations |
| Q40510485 | Age-dependent differences in cytokine and antibody responses after experimental RSV infection in a bovine model |
| Q36523253 | Antimicrobial therapy in childhood asthma and wheezing. |
| Q60191952 | Asma y virus respiratorio sincitial. Nuevas oportunidades de intervención terapéutica |
| Q39061469 | Atomic force microscopic investigation of respiratory syncytial virus infection in HEp-2 cells. |
| Q37116725 | Characterization of large mumps outbreak among vaccinated Palestinian refugees |
| Q34450231 | Characterization of the resistance of SJL/J mice to pneumonia virus of mice, a model for infantile bronchiolitis due to a respiratory syncytial virus |
| Q36839725 | Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. |
| Q38383297 | Clinical translation of RNAi-based treatments for respiratory diseases |
| Q39391286 | Comparison of direct immunofluorescence, conventional cell culture and polymerase chain reaction techniques for detecting respiratory syncytial virus in nasopharyngeal aspirates from infants |
| Q52368757 | Computational redesign of human respiratory syncytial virus epitope as therapeutic peptide vaccines against pediatric pneumonia. |
| Q45364174 | Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children |
| Q40095420 | Converting everolimus to mycophenolate mofetil ameliorated prolonged respiratory syncytial virus infection in a child after heart transplantation |
| Q40073593 | Detection of respiratory syncytial virus (RSV) at birth in a newborn with respiratory distress |
| Q26991548 | Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implications |
| Q37115056 | Directly transmitted viral diseases: modeling the dynamics of transmission |
| Q46170712 | Effect of reduction in household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled trial. |
| Q41877878 | Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study |
| Q36299475 | Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India |
| Q36106525 | Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics |
| Q41448272 | Genetic variability in G2 and F2 region between biological clones of human respiratory syncytial virus with or without host immune selection pressure |
| Q40590069 | Human Respiratory Syncytial Virus: Infection and Pathology. |
| Q45417824 | Human metapneumovirus infections cause similar symptoms and clinical severity as respiratory syncytial virus infections |
| Q55119368 | Human respiratory syncytial virus and hospitalization in young children in Italy. |
| Q40430519 | Human respiratory syncytial virus and other viral infections in infants receiving palivizumab |
| Q27021304 | Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design |
| Q36112917 | Infection by the respiratory syncytial virus in infants and young children at high risk |
| Q36178645 | Inhibition of protein kinase C epsilon causes ciliated bovine bronchial cell detachment |
| Q57158184 | Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells |
| Q42208785 | Ion flux in the lung: virus-induced inflammasome activation |
| Q33289824 | Kinetics of antibody-induced modulation of respiratory syncytial virus antigens in a human epithelial cell line |
| Q35231239 | Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze |
| Q38947374 | Maturation of Airway Defensive Reflexes Is Related to Development of Feeding Behavior during Growth in Rabbits |
| Q49955766 | Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease. |
| Q37179280 | Mucosal antibody responses are directed by viral burden in children with acute influenza infection |
| Q34492674 | Neonatal innate immunity to infectious agents |
| Q33415268 | Neurological complications of respiratory syncytial virus infection: case series and review of literature |
| Q39144786 | Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview |
| Q38628928 | New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. |
| Q34692122 | New immune pathways from chronic post-viral lung disease |
| Q33558475 | Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology |
| Q36993991 | Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination. |
| Q36922280 | Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease |
| Q40833577 | Pediatric Asthma and Viral Infection. |
| Q44993630 | Potent induction of IFN-γ production from cord blood NK cells by the stimulation with single-stranded RNA. |
| Q40528355 | Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada |
| Q45365836 | Prevalence of respiratory syncytial virus infection among hospitalized children presenting with acute lower respiratory tract infections |
| Q37841264 | Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis |
| Q31127401 | Prospective study of Human Bocavirus (HBoV) infection in a pediatric university hospital in Germany 2005/2006. |
| Q37721415 | Prospects for defined epitope vaccines for respiratory syncytial virus |
| Q36627248 | Prospects of RNA interference therapy in respiratory viral diseases: update 2006. |
| Q37333053 | RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy |
| Q37412509 | Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus. |
| Q38600929 | Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus |
| Q81484313 | Respiratory infections and asthma |
| Q24535536 | Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein |
| Q34486238 | Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses |
| Q37051620 | Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. |
| Q45399642 | Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database |
| Q45388435 | Respiratory syncytial virus infection in children admitted to hospital but ventilated mechanically for other reasons |
| Q34728523 | Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study |
| Q38076133 | Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression |
| Q37754763 | Respiratory syncytial virus: immunopathology and control |
| Q26796151 | Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention? |
| Q35689593 | Role of respiratory syncytial virus in acute otitis media: implications for vaccine development |
| Q115694868 | Roles of Human Respiratory Syncytial Virus Proteins in Immune Responses |
| Q37581916 | Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia |
| Q58566365 | State of the Art in Respiratory Syncytial Virus Drug Discovery and Development |
| Q37174419 | Suppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species |
| Q37264759 | Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection |
| Q35101883 | The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model |
| Q89691871 | The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis |
| Q45385122 | The effects of disodium cromoglycate on enhanced adherence of Haemophilus influenzae to A549 cells infected with respiratory syncytial virus |
| Q37264287 | The role of infection in asthma. |
| Q36411968 | Treatment of respiratory virus infections |
| Q36961083 | Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. |
| Q37072079 | Understanding the mechanisms of viral induced asthma: new therapeutic directions |
| Q40231098 | Viruses associated with influenza-like-illnesses in Papua New Guinea, 2010. |
| Q24679785 | Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis |
Search more.